When Purpose Calls: Karim Smaira on Walking Away from Comfort to Build a Legacy

When Purpose Calls: Karim Smaira on Walking Away from Comfort to Build a Legacy | Reimagining YouIn this deeply inspiring episode of Reimagining You, Dr. Elie Daher sits with Karim Smaira, CEO & Co-Founder of Genpharm, whose journey embodies courage, conviction, and legacy-driven leadership.Karim did what many only dream of:He walked away from a prestigious global role at Merck, left the comfort of corporate success, invested his life savings, and built a company that now transforms the lives of rare disease patients across the Middle East.This is not just a business story, it’s a leadership awakening.In this episode, you’ll discover:* The courage behind leaving a high-ranking corporate position* How Karim identified a massive regional gap in rare diseases* The emotional and financial risks of starting Genpharm* Why family support became the backbone of his entrepreneurial leap* How referrals became their unexpected growth engine* The impact of bringing gene therapy and specialty care to the region* What it means to lead with values, humility, and purposeKey Themes We Explore Together:– Success vs. significance– Reinventing your leadership identity– Building trust in an underserved market– Influence with integrity– Purpose-led entrepreneurship– Creating a legacy that outlives your titleKarim’s journey is a reminder that purpose doesn’t whisper; it calls. And when you answer that call, everything in your life and leadership transforms.If you’re standing at a crossroads: career, identity, or purpose, this episode will speak directly to you.About Reimagining YouHosted by Dr. Elie Daher, the show features global leaders, founders, thinkers, and visionaries who have reinvented themselves and built meaningful impact.91,000+ subscribers. 500,000+ views in the last 4 months.If this episode inspires you:Like, comment, and share it with someone who needs this message today.Subscribe for more conversations on identity, leadership, and reinvention.